News
1 - 1 of 1 news items
-
19 December 2008 /Prices and reimbursement
Consultation responses on the future reimbursement status of dihydropyridine calcium antagonists (C08CA)
The Danish Medicines Agency's assessment of the future reimbursement status of the dihydropyridine calcium antagonists (C08CA) were submitted for consultation with 11 November 2008 as the consultation deadline.
